Financial reports
NT 10-K
Notice of late annual filing
1 Apr 13
10-Q
2012 Q3
Quarterly report
14 Nov 12
10-Q
2012 Q2
Quarterly report
10 Aug 12
10-Q
2012 Q1
Quarterly report
10 May 12
10-K
2011 FY
Annual report
28 Mar 12
10-Q
2011 Q3
Quarterly report
14 Nov 11
10-Q
2011 Q2
Quarterly report
15 Aug 11
10-K/A
2010 FY
Annual report (amended)
30 Jun 11
10-Q
2011 Q1
Quarterly report
9 May 11
10-K
2010 FY
Annual report
30 Mar 11
Current reports
8-K
Entry into a Material Definitive Agreement
11 Jul 13
8-K
Submission of Matters to a Vote of Security Holders
24 Jun 13
8-K
Entry into a Material Definitive Agreement
17 Apr 13
8-K
Entry into a Material Definitive Agreement
1 Apr 13
8-K
Other Events
27 Mar 13
8-K
Entry into a Material Definitive Agreement
11 Mar 13
8-K
Cost Associated with Exit or Disposal Activities
5 Mar 13
8-K
Departure of Directors or Certain Officers
8 Jan 13
8-K
Cost Associated with Exit or Disposal Activities
30 Nov 12
8-K
NeurogesX Reports Third Quarter 2012 Results
14 Nov 12
Registration and prospectus
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Mar 13
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Mar 13
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Mar 13
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Mar 13
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Mar 13
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Mar 13
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Mar 13
POS AM
Prospectus update (post-effective amendment)
25 Mar 13
POS AM
Prospectus update (post-effective amendment)
25 Mar 13
POS AM
Prospectus update (post-effective amendment)
25 Mar 13
Proxies
Other
EFFECT
Notice of effectiveness
26 Mar 13
EFFECT
Notice of effectiveness
26 Mar 13
EFFECT
Notice of effectiveness
26 Mar 13
EFFECT
Notice of effectiveness
26 Mar 13
CT ORDER
Confidential treatment order
17 Sep 12
EFFECT
Notice of effectiveness
12 Apr 12
CORRESP
Correspondence with SEC
6 Jan 12
CORRESP
Correspondence with SEC
29 Nov 11
UPLOAD
Letter from SEC
23 Nov 11
EFFECT
Notice of effectiveness
8 Sep 11
Ownership
SC 13G/A
NeurogesX Inc
13 Feb 17
SC 13G/A
NeurogesX Inc
9 Feb 17
SC 13G/A
NeurogesX Inc
17 Feb 16
SC 13G/A
NeurogesX Inc
11 Feb 16
SC 13G
NeurogesX Inc
7 Jan 16
SC 13G/A
NeurogesX Inc
18 Sep 15
SC 13G
NeurogesX Inc
17 Sep 15
SC 13G
NeurogesX Inc
10 Feb 15
SC 13G/A
NeurogesX Inc
18 Feb 14
SC 13D/A
ARCH VENTURE FUND V LP
4 Aug 11